Abstract
Compared with bare metal stents, drug-eluting stents (DES) reduce major adverse cardiac events (MACE) in the first year after PCI, but still have an ongoing 2%–3% annual event rate. The DynamX Coronary Bioadaptor is a 71 μm cobalt-chromium platform with a novel “uncaging” mechanism of circumferential rings, which maintains the axial links between the rings following uncaging. Unlike conventional metallic DES, this allows positive adaptive remodelling and restoration of vascular compliance and geometry, with potential long-term benefits.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
